ArticleCureus2026
Intractable Nausea as the Initial Presentation of Neuromyelitis Optica.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune condition of the central nervous system, primarily involving the optic nerves and spinal cord. Patients typically present with visual disturbance, limb weakness or sensory deficits, and bladder dysfunction. However, atypical and nonspecific presentations may occur, including persistent nausea and vomiting due to involvement of the area postrema. We report the case of a 26-year-old female patient who presented with a one-month history of intractable vomiting, associated with epigastric discomfort (worse prior to vomiting), reduced appetite, and significant weight loss of approximately 7-8 kg over one month. She had been admitted two times prior to presentation, with extensive investigations that were unremarkable. During admission, she also reported blurred vision and was noted to have horizontal nystagmus. Brain MRI demonstrated areas of altered signal intensity involving the brainstem and cervicomedullary junction, along the floor of the fourth ventricle, initially raising concern for Wernicke's encephalopathy. She received intravenous thiamine without clinical improvement. Further evaluation, including whole-spine MRI and autoimmune serology, revealed positivity for aquaporin-4 (AQP4) IgG antibodies, confirming NMOSD. She was treated with intravenous methylprednisolone and tocilizumab, resulting in marked symptomatic improvement. This case highlights NMOSD as an important and often under-recognized cause of intractable nausea and vomiting, which may delay diagnosis and treatment. A thorough neurological history and examination are essential in patients with persistent unexplained vomiting to ensure timely recognition and initiation of appropriate therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.